Investigating the benefits and challenges of Total Quality Management implementation in the pharmaceutical companies

Kateryna Petliushenko, Vikas Kumar, Jeremy Zwiegelaar, John Noonan, Jose A Garza-Reyes

Research output: Contribution to conferenceConference Paperpeer-review

Abstract

Pharmaceutical companies in Eastern European region are facing urgent quality tools implementation due to fierce global competition. The aim of this research is to provide current understanding of TQM in this region and provide further guidance on how to improve quality standards and techniques. The study follows a qualitative method and data was collected through 5 semi-structured interviews. The study highlights that TQM in pharmaceutical industry in this
region is not well developed. The findings shows that there is lack of senior management commitment to TQM principles explanation and emphasises on its importance. Additionally, lack of governmental influence on quality standards and budgeting problems also affects TQM development. Moreover, there is a believe that TQM will not influence the overall performance of the company in the positive manner, since the development of such quality improvement
method has to be efficiently budgeted and under current economic and political circumstances it is not possible.
Original languageEnglish
Pages2-15
Number of pages15
Publication statusPublished - 26 Jun 2018
EventBritish Academy of Management - University of the West of England, Bristol, United Kingdom
Duration: 4 Sept 20186 Sept 2018
http://conference.bam.ac.uk/BAM2018/htdocs/conference_papers.php?track_name=Operations,%20Logistics%20and%20Supply%20Chain%20Management#

Conference

ConferenceBritish Academy of Management
Abbreviated titleBAM
Country/TerritoryUnited Kingdom
CityBristol
Period4/09/186/09/18
Internet address

Keywords

  • TQM, Pharmaceutical, Eastern Europe, Benefits, Challenges

Fingerprint

Dive into the research topics of 'Investigating the benefits and challenges of Total Quality Management implementation in the pharmaceutical companies'. Together they form a unique fingerprint.

Cite this